RhumbLine Advisers’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-32,999
Closed -$144K 4143
2025
Q1
$144K Buy
32,999
+1,332
+4% +$5.82K ﹤0.01% 3272
2024
Q4
$148K Sell
31,667
-662
-2% -$3.09K ﹤0.01% 3341
2024
Q3
$227K Buy
32,329
+1,508
+5% +$10.6K ﹤0.01% 3174
2024
Q2
$211K Buy
30,821
+30,528
+10,419% +$209K ﹤0.01% 3198
2024
Q1
$4.14K Sell
293
-1
-0.3% -$14 ﹤0.01% 4004
2023
Q4
$2.21K Hold
294
﹤0.01% 4085
2023
Q3
$4.41K Hold
294
﹤0.01% 4006
2023
Q2
$4.67K Buy
+294
New +$4.67K ﹤0.01% 4103
2022
Q2
Sell
-11,921
Closed -$156K 3089
2022
Q1
$156K Sell
11,921
-967
-8% -$12.7K ﹤0.01% 2809
2021
Q4
$227K Sell
12,888
-28
-0.2% -$493 ﹤0.01% 2799
2021
Q3
$280K Buy
12,916
+211
+2% +$4.57K ﹤0.01% 2794
2021
Q2
$445K Buy
12,705
+1,760
+16% +$61.6K ﹤0.01% 2610
2021
Q1
$1.08M Sell
10,945
-879
-7% -$86.7K ﹤0.01% 2157
2020
Q4
$1.28M Buy
11,824
+859
+8% +$93.1K ﹤0.01% 2036
2020
Q3
$1.13M Sell
10,965
-872
-7% -$89.8K ﹤0.01% 1943
2020
Q2
$2.47M Buy
11,837
+3,449
+41% +$720K ﹤0.01% 1608
2020
Q1
$820K Buy
8,388
+1,066
+15% +$104K ﹤0.01% 1970
2019
Q4
$843K Buy
7,322
+68
+0.9% +$7.83K ﹤0.01% 2159
2019
Q3
$395K Sell
7,254
-13
-0.2% -$708 ﹤0.01% 2429
2019
Q2
$864K Sell
7,267
-436
-6% -$51.8K ﹤0.01% 2118
2019
Q1
$404K Sell
7,703
-87
-1% -$4.56K ﹤0.01% 2415
2018
Q4
$245K Buy
7,790
+2,308
+42% +$72.6K ﹤0.01% 2635
2018
Q3
$332K Sell
5,482
-25
-0.5% -$1.51K ﹤0.01% 2468
2018
Q2
$292K Buy
+5,507
New +$292K ﹤0.01% 2546
2017
Q2
Sell
-2,870
Closed -$78K 2922
2017
Q1
$78K Buy
2,870
+887
+45% +$24.1K ﹤0.01% 2795
2016
Q4
$58K Sell
1,983
-494
-20% -$14.4K ﹤0.01% 2821
2016
Q3
$102K Buy
2,477
+50
+2% +$2.06K ﹤0.01% 2805
2016
Q2
$77K Buy
2,427
+573
+31% +$18.2K ﹤0.01% 2942
2016
Q1
$96K Buy
1,854
+10
+0.5% +$518 ﹤0.01% 2901
2015
Q4
$176K Buy
1,844
+88
+5% +$8.4K ﹤0.01% 2837
2015
Q3
$145K Buy
1,756
+68
+4% +$5.62K ﹤0.01% 2877
2015
Q2
$274K Buy
1,688
+1,008
+148% +$164K ﹤0.01% 2718
2015
Q1
$275K Buy
680
+268
+65% +$108K ﹤0.01% 2661
2014
Q4
$222K Buy
+412
New +$222K ﹤0.01% 2748